Archive for the 'Pleural Biopsy' Category
Surgery to remove a sample of the tissue that lines the lungs and the inside of the chest wall which is then examined to check for disease or infection.
November 3rd, 2006. Mesothelioma with non-pleural malignancy: a red herring or just an uncommon pairing?
We report four cases of female patients with MPM referred for palliation of symptoms thought to be due to previous non-pleural malignancy. With emerging novel treatments for MPM, this article discusses four unusual cases of MPM occurring in the setting of other malignancy, highlights the importance of considering a primary diagnosis of MPM even in patients with other malignancy, and reinforces the benefits of video-assisted surgical biopsy which allows simultaneous diagnosis and treatment.
November 1st, 2006. Video-assisted diagnostic thoracoscopy
Video-assisted thoracoscopy is a safe and effective guiding tool if performed by experienced thoracic surgeons able to convert to thoracotomy. It is to be noted that interpretation of intraoperative findings plays a decisive role in interdisciplinary diagnostics of intrathoracal diseases.
September 29th, 2006. Pleural Mesothelioma: Sensitivity and Incidence of Needle Track Seeding after Image-guided Biopsy versus Surgical Biopsy
Conclusion: Image-guided core-needle biopsy in patients with malignant pleural mesothelioma has a lower incidence of needle track seeding than surgical biopsy and has a high sensitivity for diagnosis.
September 15th, 2006. Malignant mesothelioma: A ten years experience
Discussion: As demonstrated by the small series in ten years, malignant mesothelioma is a rare tumour. Relationship with asbestos exposure was proven in 67% of cases. Chemotherapy associated with talc pleurodesis increased survival and palliated symptoms.
Posted in Carboplatin, Causation, Chemotherapy, Cisplatin (Platinol ®), Determining Efficacy, Diagnosis & Differentiation, Full Archive, Gemcitabine (Gemzar), General, Occupational Asbestos Exposure, Pemetrexed (Alimta), Pleural Biopsy, Pleural Effusion, Pneumonectomy, Radiation, Surgery, Survival, Symptoms & Symptom Management, Treatment, Type of Assessment: | No Comments »
September 6th, 2006. A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions
Conclusions: We have developed a test that is able to distinguish between lung adenocarcinoma and mesothelioma in cells collected from pleural effusions.
August 21st, 2006. Diagnostic value of thoracoscopic pleural biopsy for pleurisy under local anaesthesia
Conclusion: Pleural biopsy by thoracoscopy under local anaesthesia should be actively carried out in patients with pleurisy, because the technique has a high diagnostic rate and can be easily and safely carried out.
February 10th, 2006. Video-assisted thoracoscopic surgery in diagnosis and treatment of pleuritis
Conclusions: Specificity of video-assisted thoracoscopic surgery in pleural diseases reaches 93.0%. Video-assisted thoracoscopic surgery is necessary even in cases of failed "blind" biopsies and possible in elderly patients. Video-assisted thoracoscopic surgery provides not only easy morphologic verification of pleural diseases but also performance of chemopleurodesis.
January 27th, 2006. Differential diagnosis of preneoplastic lesions of the pleura and of early mesothelioma: immunohistochemical and morphological findings
Early infiltrative growth is characteristic of so called early mesothelioma. A useful immunohistochemical panel for the differential diagnosis consists of anti-cytokeratin, Ck 5/6, calretinin, EMA and MiB-1, whereas the immunohistochemical detection of telomerase is not helpful.
November 21st, 2005. Use of imaging in the management of malignant pleural mesothelioma
In view of its pattern of growth, MPM is a challenging disease to image by any method, and it behaves quite differently from lung cancer. This review aims to highlight the practical aspects of assessing malignant pleural mesothelioma.
November 1st, 2005. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies
Conclusions: Various histologic clues favor a benign over a malignant mesothelial proliferation and vice versa. Invasion is the most reliable criterion for determining that a mesothelial proliferation is malignant. When there is any doubt that a pleural biopsy represents a malignancy, we recommend a diagnosis of atypical mesothelial proliferation.
November 1st, 2005. Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies
Conclusion: Pathologists should be aware of the varied histologic patterns of diffuse malignant mesothelioma when evaluating pleural biopsies.
May 5th, 2004. Pleural Biopsy: A Reliable Method for Determining the Diagnosis But Not Subtype in Mesothelioma
Conclusions: Open pleural biopsy is accurate and should be considered the gold standard diagnostic method for MPM. It is less sensitive for determining histologic subclass, particularly with nonepithelial subtypes.
July 9th, 2001. Percutaneous Image-Guided Cutting Needle Biopsy of the Pleura in the Diagnosis of Malignant Mesothelioma
Conclusions: Image-guided percutaneous CNB of pleural thickening is a safe procedure, with 86% sensitivity for detecting malignant mesothelioma. Pleural thickening of <= 5 mm may be successfully sampled.
|
|  |
